Material Type

• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (1)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Other (1)
• Plasma (single spun) (2)
• Saliva (1)
• Serum (4)
• Solid tissue (non viable) (1)
• Stool (1)
• Swab medium (1)
• Urine (first morning) (1)
• Urine (random) (1)

Microscopic Assessment

• Affected (2)
• Non-affected (1)
• Not applicable (3)

Storage Temperature

• RT (2)
• -85°C to -60°C (5)

Associated Data

• Biomarker datasets (3)
• Clinical records (6)
• Followup records (4)
• Freezer temperature logs (4)
• Genomic datasets (1)
• Microbiological results (2)
• Participant Ethnicity (3)
• Pre-analytical data (2)
• Quality indicators (2)
• Survey data (2)
• Treatment records (3)

Timeframe

• Immediate (3)
• 0 - 3 months (5)
• 3 - 6 months (2)
• > 6 months (3)

Participant Count

• 11 - 100 (6)

Sex

• Unknown (1)
• Both sexes (5)

Age Range

• Child (6 - 12 years) (1)
• Adolescent (12 - 18 years) (2)
• Young adult (18 - 40 years) (3)
• Adult (> 40 years) (2)

Biobank Services

• Ability to recontact (2)
• Cell culture (1)
• Data analytics (1)
• Digital imaging (2)
• Infectious strain isolation (1)
• Molecular Extractions (1)
• Nucleic acid extraction (3)

Collection Type

• Case-control (1)
• Clinical Trial (1)
• Cross-sectional (1)
• Disease specific (2)
• Longitudinal (1)

Consent Restriction

• No Commercial restriction (5)
• No Disease area restriction (6)
• No Export restriction (6)
• No Genetic analysis restriction (4)
• No Human genetic analysis restriction (3)
• No restrictions (1)
• No Project specific restriction (6)
• No Scope of use restriction (4)

Collection Status

• Completed (4)
• In progress (2)

Access Condition

• Open to applicants (3)
• Open in response to specific calls (1)
• Open only through collaboration (1)
• Closed to access (1)

Country

• Belgium (1)
• Peru (1)
• Spain (1)
• Switzerland (1)
• United Kingdom of Great Britain and Northern Ireland (1)
• United States (1)

County